Oligonucleotide Synthesis Market Research Report- Global Forecast To 2022

Oligonucleotide Synthesis Market Research Report- Global Forecast To 2022

ID: MRFR/LS/1721-HCRR | June, 2018 | Region: Global | 80 pages | Half-Cooked Research Reports

Oligonucleotide Synthesis market information, by Product Type (synthesized oligonucleotides, reagents and equipment.), by Application (diagnostic, genetic testing, research, therapeutics, gene synthesis), by End User (academic research institutes, diagnostic laboratories, pharmaceutical) - Forecast till 2022

 Market Synopsis of Oligonucleotide Synthesis Market:

Market Scenario:                      

The global market of oligonucleotide synthesis is growing at a rapid pace. The global oligonucleotide synthesis market is growing at the CAGR of around 10.3% for the forecasted period. The major factors that are influencing the market for oligonucleotide synthesis are increasing advancement in field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investment by the government for the development of genomic technologies, increasing demand for oligonucleotide synthesis technologies by the public and private research firms. Furthermore increasing application of oligonucleotide synthesis in diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others is further influencing the growth of the oligonucleotide synthesis market globally.

Study objectives of the Market:

  • Providing a detail analysis of the market structure along with forecast for the next 7 years related to various segments and sub-segments of the Oligonucleotide Synthesis market.

  • Giving insights about factors affecting the market growth.

  • Analyzing the market based on price analysis, supply chain analysis, Porters Five Force analysis etc.

  • Giving the past revenue and estimated future revenue of the market’s segments and sub-segments with respect to the main market and various markets globally.

  • Giving regional level analysis of the market with respect to the current market size and future prospect.

  • Giving regional level analysis of the market with respect to segments, by product types, by application, by end user, also giving regional level analysis of the market’s sub-segments.

  • Providing an overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing the market’s competitive structure.

  • Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments in the global Oligonucleotide Synthesis market. 



Global oligonucleotide synthesis market has been segmented on the basis of product type which comprises synthesized oligonucleotides, reagents and equipment. On the basis of application the market is segmented into diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others. Furthermore on the basis of end users the market is segmented into academic research institutes, diagnostic laboratories and pharmaceutical & biotechnology companies.

Regional Analysis of Oligonucleotide Synthesis Market:                                     

North America is the largest market of global oligonucleotide synthesis market. The North American market for oligonucleotide synthesis is expected to grow at the CAGR of 9.8%. Europe is the second largest market for oligonucleotide synthesis which is expected to grow at a CAGR of 10.0%. Asia Pacific region is expected to be fastest growing region of the global oligonucleotide synthesis market.

Key Players for Oligonucleotide Synthesis Market:                                    

Some of the key players in this market are: Integrated DNA Technologies, Inc (U.S), GE Healthcare (U.S.), Agilent Technologies Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Bioautomation Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), and Nitto Denko Avecia Inc. (Japan) and others.

The report of Oligonucleotide Synthesis market by Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

Intended Audience

  • Oligonucleotide Synthesis Manufacturers

  • Pharmaceutical companies

  • Biotechnology Companies

  • Academic research institutes

  • Government institutes

Table of Contents

1... Report Prologue

2... Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

3... Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4... Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5... Market Factor Analysis

5.1 Value/Supply Chain Analysis

5.2 Porter's 5 Forces Analysis

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

6... Global Oligonucleotide Pool Library market, By Types (USD Million)

6.1 Introduction

6.2 Historical Market Growth

6.3 Y-O-Y Growth Projections By Types

6.4 Market Size By Types

6.4.1 DNA Pool

6.4.2 RNA Pool

7... Global Oligonucleotide Pool Library market, By Methods (USD Million)

7.1 Introduction

7.2 Historical Market Growth

7.3 Y-O-Y Growth Projections By Methods

7.4 Market Size By Methods

7.4.1 Electrochemical-synthesis

7.4.2 Exon trapping

7.4.3 Targeted regions trapping

7.4.4 Microarray synthesis technology

7.4.5 Others

8... Global Oligonucleotide Pool Library market, By Application (USD Million)

8.1 Introduction

8.2 Historical Market Growth

8.3 Y-O-Y Growth Projections By Application

8.4 Market Size By Procedure

8.4.1 Research

8.4.2 Therapeutics

8.4.3 CRISPR/Cas9 designs

8.4.4 Massively Parallel Reporter Assays (MPRA)

8.4.5 Diagnostic

8.4.6 Genetic Testing

8.4.7 Sequence targeting

8.4.8 Gene synthesis

8.4.9 Library preparation

8.4.10 Drug Target Screening

8.4.11 Others

9... Global Oligonucleotide Pool Library market, By End User (USD Million)

9.1 Introduction

9.2 Historical Market Growth

9.3 Y-O-Y Growth Projections By End User

9.4 Market Size By Procedure

9.4.1 Academic Research Institutes

9.4.2 Diagnostic Laboratories

9.4.3 Pharmaceutical and Biotechnology Companies

9.4.4 Others

10. Global Oligonucleotide Pool Library market, By Region (USD Million)

10.1 Introduction

10.2 Y-O-Y Growth Projections By Region

10.3 Market Size By Region

10.3.1 Americas North America The US Canada South America

10.3.2 Europe Western Europe Germany France Italy Spain UK Eastern Europe

10.3.3 Asia-Pacific Asia China India Japan Pacific

10.3.4 Middle East & Africa

11. Company Landscape

11.1 Introduction: Key Players

11.2 Market Share Analysis

11.3 Key Development & Strategies

12. Company Profiles

12.1 Agilent.

12.1.1 Company Overview

12.1.2 Types/Business Segment Overview

12.1.3 Financial Updates

12.1.4 Key Developments

12.2 Creative Biogene

12.2.1 Company Overview

12.2.2 Types/Business Segment Overview

12.2.3 Financial Updates

12.2.4 Key Developments

12.3 CustomArray Inc.

12.3.1 Company Overview

12.3.2 Types/Business Segment Overview

12.3.3 Financial Updates

12.3.4 Key Developments

12.4 Eurofins Genomics.

12.4.1 Company Overview

12.4.2 Types/Business Segment Overview

12.4.3 Financial Updates

12.4.4 Key Developments

12.5 Integrated DNA Technologies, Inc.

12.5.1 Company Overview

12.5.2 Types/Business Segment Overview

12.5.3 Financial Updates

12.5.4 Key Developments

12.6 LC Sciences

12.6.1 Company Overview

12.6.2 Types/Business Segment Overview

12.6.3 Financial Updates

12.6.4 Key Developments

12.7 LGC Biosearch Technologies

12.7.1 Company Overview

12.7.2 Types/Business Segment Overview

12.7.3 Financial Updates

12.7.4 Key Developments

12.8 Mycroarray

12.8.1 Company Overview

12.8.2 Types/Business Segment Overview

12.8.3 Financial Updates

12.8.4 Key Developments

12.9 Sigma-Aldrich Co. LLC

12.9.1 Company Overview

12.9.2 Types/Business Segment Overview

12.9.3 Financial Updates

12.9.4 Key Developments

12.10 Twist Bioscience

12.10.1 Company Overview

12.10.2 Types/Business Segment Overview

12.10.3 Financial Updates

12.10.4 Key Developments

12.11 Others

13. Conclusion


13.1.1........ FROM CEO’S VIEWPOINT




14. Appendix